Introduction
In patients with kidney failure cardiovascular complications are a major clinical problem. The most important is left ventricular hypertrophy and the main cause of death in these patients is due to cardiac problems (1, 2) . Cardiac risk is increased with much more frequency in hemodialysis patients, compared with age matched controls (1-3). It had been known for a long time that plaque in arteries are more frequent in patients on hemodialysis (1) . In fact patients under dialysis suffer from excessive mortality due to atherosclerotic cardiovascular disease in comparison to general population (4) . This is frequently attributed to the rapid progressive atherosclerosis. Indeed, various risk factors of atherosclerotic cardiovascular disease in the general population such as lipid abnormalities, glucose intolerance, hypertension and left ventricular hypertrophy are more commonly observed in hemodialysis (4, 5) . Ultrasonic assessment of plaques in the carotid and femoral arteries are extensively used as a surrogate marker of atherosclerosis in coronary arteries (3) . However, prospective evaluations about the association of arterial plaque with hypertrophy of left ventricle and also left ventricular ejection fraction are scares and seems to be lacking in hemodialysis patients. 
Morteza

Ethical approval
All patients signed the consent form for participation in this study. Research study was approved by the ethics committee of Shahrekord University of Medical Sciences, Iran.
Statistical analysis
For statistical analysis descriptive data were expressed as Mean (SD) and frequency distributions. Comparison between groups were performed using Chi-square, Mann Whitney U, KruskalWallis and Fisher's exact tests. For correlations Spearman's rho test, partial correlation test with adjustment for ages of patients, Phi & Cramer's V, Pearson and Eta tests were applied too. All statistical analysis were performed using the SPSS (version 11.00). Statistical significance was inferred at a p value< 0.05.
Results
The total patients were 61. Table 1 shows the mean of data. Tables  2, 3 and 4 show the frequency distributions of chest pain, stages of hypertension and stages of LVH. A significant positive association between plaque score and presence of diabetes mellitus was observed (p=0.004). Also, a significant positive correlation between plaque score with left ventricular hypertrophy (r= 0.259, p=0.023) was found. Moreover, a significant positive association between plaque score and duration of dialysis (r= 0.239, p=0.033) and a positive correlation between plaque score with stages of hypertension (r= 0.240, p=0.032) was detected too. 
Discussion
In this study, we found a positive association between left ventricular hypertrophy and duration of dialysis was seen. An inverse correlation of plaque score with percent of left ventricular ejection fraction was found. A significant correlation between plaque score with left ventricular hypertrophy and also a positive correlation between plaque score with duration of dialysis was detected. Studies regarding the arterial plaques and left ventricular hypertrophy in dialysis patients showed interesting findings. Strauman et al. (8) in an investigation on 62 patients on maintenance hemodialysis observed, 65% prevalence of left ventricular hypertrophy. They showed, age, body mass index, and duration of hypertension was associated with left ventricular hypertrophy and asymmetric septal hypertrophy. Greaves et al. (9) all the vessels except on the carotid sites. They concluded that the process of advance atherosclerosis might be started with the beginning of kidney failure. They suggested that hemodialysis treatment may not a potential factor to accelerate arthrosclerosis. They concluded that the progression of atherosclerosis might be related to atherogenic factors operative before regular dialysis (11). Savage et al. in an investigation on 24 dialysis patients detected, the more prevalence of plaque in carotid and femoral artery. Also this study showed, the association between femoral artery plaque and age (4). Mallion et al. (14) found that the prevalence of arterial changes is more evident in subjects with left ventricular hypertrophy. They believed that when there is left ventricular hypertrophy, this arterial changes is similar in severity to the left ventricular hypertrophy and in particular concentric.
Conclusion
Our results provide the evidence of the association of carotid-femoral plaques with left ventricular hypertrophy and especially inverse correlation of plaque score with left ventricular ejection fraction, means that arterial plaques and cardiovascular involvement especially left ventricular hypertrophy in hemodialysis patients could have an atherosclerotic base although other factors are involved in this process. The association of carotid-femoral arterial plaques to left ventricular hypertrophy may confirm the arterial-cardiac interaction and further highlights the importance of structural changes in large arteries of the pathogenesis of left ventricular hypertrophy in hemodialysis patients. However, the question is whether carotid ultrasonography added applicable information to echocardiography measured left ventricular hypertrophy in hemodialysis patients. Therefore in the meantime further clinical study into this important aspect of hemodialysis patients is needed.
